US2011301259A1PendingUtilityA1
Temporal intraluminal stent, methods of making and using
Est. expiryOct 25, 2026(~0.3 yrs left)· nominal 20-yr term from priority
B29C 41/14B29C 41/34A61F 2002/828A61F 2/86A61F 2002/91558A61F 2/88A61F 2002/91591A61F 2210/0076A61F 2002/91525A61F 2002/91541A61F 2002/91566B29K 2067/046A61F 2/915A61F 2/82A61L 27/54A61F 2/91A61L 27/28A61L 27/14
55
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A biodegradable polymer stent with radiopacity and a method of making and using a stent with enhanced mechanical strength and/or controlled degradation for use in a bodily lumen is described.
Claims
exact text as granted — not AI-modified1 - 30 . (canceled)
31 . A biodegradable polymer stent comprising an aliphatic polyester polymer and a salt selected from the group of salts: phosphate buffer salt, citrate buffer salt and sodium chloride wherein the salt is present in an amount sufficient to increase the degradation rate compared to the same stent without the salt.
32 . The stent of claim 31 wherein the salt comprises from 0.01 to 15% of the percent weight of the stent.
33 . The stent of claim 31 wherein the salt comprises from 2.0 to 8% of the percent weight of the stent.
34 . The stent of claim 31 wherein the salt is a phosphate salt.
35 . The stent of claim 31 wherein the polymer is comprised of poly-L-lactic acid or poly D,L-lactic acid.
36 . The stent of claim 31 wherein the polymer is a homo-polymer.
37 . The stent of claim 31 wherein the polymer is a co-polymer.
38 . A method of increasing the rate of biodegradation of a biodegradable polymer stent comprising an aliphatic polyester polymer and a salt selected from the group of salts: phosphate buffer salt, citrate buffer salt and sodium salt comprising the steps of:
i. combining the salt with the polymer in an amount sufficient to increase the degradation rate compared to the same stent without the salt; and, ii. forming the polymer into a stent.
39 . The method of claim 38 wherein the salt comprises from 0.01 to 15% of the percent weight of the stent.
40 . The method of claim 38 wherein the salt comprises from 2.0 to 8% of the percent weight of the stent.
41 . The method of claim 38 wherein the salt is a phosphate salt.
42 . The method of claim 38 wherein the polymer is comprised of poly-L-lactic acid or poly D,L-lactic acid.
43 . The method of claim 38 wherein the polymer is a homo-polymer.
44 . The method of claim 38 wherein the polymer is a co-polymer.Join the waitlist — get patent alerts
Track US2011301259A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.